About half of men diagnosed with prostate cancer have low-risk disease. Here’s the evidence comparing active surveillance to curative therapy in this large group of patients…
Through increased steroid receptor expression, tumors can adopt a drug-resistance mechanism that is essential for the life of their human host. This entanglement tactic makes it difficult to devise treatment approaches aimed at deactivating the tumor’s drug resistance while not compromising the patient.
Radiation treatment for prostate cancer inadvertently irradiates the surrounding pelvic bones, which hold more than half the body’s active bone marrow mass. But a Cleveland Clinic study finds that men who undergo the procedure have no greater risk of developing myelodysplastic syndromes than the general population.
Specialized software now combines multiparametric MRI and transrectal ultrasound images to improve targeted biopsy of suspicious lesions. The technology has the potential to significantly improve localization and characterization of prostate cancer when added to a 12-core biopsy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Results help identify active surveillance candidates